+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Neurostimulation Technologies Market 2021-2026

  • ID: 5324092
  • Report
  • May 2021
  • Region: Global
  • 121 Pages
  • BCC Research
Market Expected to Reach $9.8 Billion by 2026 from $7.1 Billion in 2021, at a CAGR of 6.9%

FEATURED COMPANIES

  • Abbott Laboratories
  • Brainsway Ltd.
  • Laborie Inc.
  • Nalu Medical Inc.
  • Neurosigma Inc.
  • Respicardia Inc.

The global neurostimulation devices market should reach $9.8 billion by 2026 from $7.1 billion in 2021 at a compound annual growth rate (CAGR) of 6.9% for the forecast period of 2021 to 2026.

  • The spinal cord stimulation (SCS) devices segment of the global neurostimulation devices market is expected to grow from $2.3 billion in 2021 to $2.7 billion in 2026 at a CAGR of 3.4% for the forecast period of 2021 to 2026.
  • The deep brain stimulation (DBS) devices segment of the global neurostimulation devices market is expected to grow from $1.2 billion in 2021 to $2.1 billion in 2026 at a CAGR of 12.8% for the forecast period of 2021 to 2026.

This report aims to provide a comprehensive study of the global market for neurostimulation technologies/devices. It provides a detailed description of the different types of neurostimulation technologies/devices (invasive and noninvasive) and their current and historical market revenues.

Neurostimulation technologies/devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.

This report also covers a detailed study of therapeutic applications of neurostimulation technologies/devices including chronic pain, Parkinson’s disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies/devices includes historical data and market projection on sales by, device type, therapeutic applications and region.

For in-depth understanding of the market, profiles of market participants, key marketed devices, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global neurostimulation technology/devices market.

The Report Includes:

  • 21 data tables and 20 additional tables
  • An overview of the global markets and technologies for neurostimulation
  • Estimation of the market size and analyses of market trends, with data from 2020, estimates for 2021 and projection of CAGR through 2026
  • Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases
  • Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies
  • Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies
  • Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth
  • Details about symptoms, progression and epidemiology of COVID-19 and discussion on impact of COVID-19 pandemic on medical industry as well as on neurostimulation market
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Comprehensive company profiles of major players of the industry, including Abbott Laboratories, Boston Scientific, Medtronic PLC, NeuroMetrix, NeuroSigma and Soterix Medical Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Brainsway Ltd.
  • Laborie Inc.
  • Nalu Medical Inc.
  • Neurosigma Inc.
  • Respicardia Inc.

Chapter 1: Introduction

  • Study Goals and Objectives
  • Scope of This Report
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Introduction to Neurostimulation
  • Types of Neurostimulation Technologies
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation
  • Hypoglossal Nerve Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation (TMS)
  • Others
  • Therapeutic Applications for Neurostimulation Technologies/Devices
  • Chronic Pain Management
  • Neurological Disorders
  • Urinary and Fecal Incontinence
  • Obstructive Sleep Apnea
  • Chronic Migraine and Headache
  • Cardiovascular Diseases
  • Gastrointestinal Disorders
  • Obesity
  • Psychiatric Disorders
  • Technology Developments
  • MRI Compatibility
  • Rechargeable and Non-rechargeable Devices

Chapter 4: Market Breakdown by Technology/Device Type

  • Global Market for Neurostimulation Devices by Type
  • Spinal Cord Stimulation (SCS) Devices
  • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • Deep Brain Stimulation (DBS) Devices
  • Sacral Nerve Stimulation (SNS) Devices
  • Vagus Nerve Stimulation (VNS) Devices
  • Hypoglossal Nerve Stimulation (HGNS) Devices
  • Market Size and Forecast
  • Transcranial Magnetic Stimulation (TMS) Devices
  • Other Types of Neurostimulation Devices

Chapter 5: Market Breakdown by Region

  • Global Markets for Neurostimulation Devices by Region
  • North America
  • Europe
  • Asia
  • RoW

Chapter 6: Market Breakdown by Application

  • Global Market for Neurostimulation Devices by Therapeutic Application
  • Chronic Pain
  • Urinary and Fecal Incontinence
  • Parkinson's Disease
  • Epilepsy
  • Obstructive Sleep Apnea (OSA)
  • Essential Tremor
  • Major Depressive Disorder (MDD)/Clinical Depression
  • Obsessive Compulsive Disorder (OCD)
  • Others

Chapter 7: Key Marketed Products and Technologies

  • Recent Therapeutic Improvements and New Indications
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation
  • Hypoglossal Nerve Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Other Types of Stimulation
  • New Indications and Neurostimulation Therapies

Chapter 8: Competitive Landscape

  • Company Market Shares by Product Segment
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Hypoglossal Nerve Stimulation Devices
  • Transcranial Magnetic Stimulation Devices
  • Transcutaneous Electrical Nerve Stimulation Devices
  • Recent Industry Activities

Chapter 9: Market Dynamics

  • Market Trends
  • Growth Drivers
  • Market Restraints

Chapter 10: Impact of COVID-19

Chapter 11: Company Profiles

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Avery Biomedical Devices Inc.
  • Axonics Modulation Technologies Inc.
  • Bioinduction Ltd.
  • Bioness Inc.
  • Biowave Corp.
  • Boston Scientific Corp.
  • Brainsway Ltd.
  • Cochlear Americas
  • CVRX Inc.
  • Electrocore Inc.
  • Inspire Medical Systems Inc.
  • Integer Holdings Corp.
  • Laborie Inc.
  • LivaNova plc
  • Mag & More GmbH
  • Magstim Inc.
  • Medtronic plc
  • Nalu Medical Inc.
  • Neuromed Consulting Inc.
  • Neurometrix Inc.
  • Neuronetics Inc.
  • Neuropace Inc.
  • Neurosigma Inc.
  • Neurovalens Ltd.
  • Nevro Corp.
  • Nexstim plc
  • Nyxoah SA
  • Respicardia Inc.
  • Soterix Medical Inc.
  • Stimwave LLC
  • Synapse Biomedical Inc.
  • Tonica Elektronik A/S
  • Xavant Technology (Pty) Ltd.

Chapter 12: Appendix: Acronyms

List of Tables
Summary Table: Global Market for Neurostimulation Devices, by Type, Through 2026
Table 1: Prevalence of Chronic Pain and High Impact Chronic Pain Among U.S. Adults, by Sociodemographic Characteristics, 2016
Table 2: U.S. Distribution Share of Location of Chronic Pin in the Body
Table 3: Prevalence of Adult Overweight and Obese Population in Select Countries, 2014-2019
Table 4: Global Market for Neurostimulation Devices, by Type, Through 2026
Table 5: Global Market for Spinal Cord Stimulation (SCS) Devices, by Region, Through 2026
Table 6: Global Market for Transcutaneous Electrical Nerve Stimulation (TENS) Devices, by Region, Through 2026
Table 7: Global Market for Deep Brain Stimulation (DBS) Devices, by Region, Through 2026
Table 8: Global Market for Sacral Nerve Stimulation (SNS) Devices, by Region, Through 2026
Table 9: Global Market for Vagus Nerve Stimulation (VNS) Devices, by Region, Through 2026
Table 10: Global Market for Hypoglossal Nerve Stimulation (HGNS) Devices, by Region, Through 2026
Table 11: Global Market for Transcranial Magnetic Stimulation (TMS) Devices, by Region, Through 2026
Table 12: Global Market for Other Types of Neurostimulation Devices, by Region, Through 2026
Table 13: Global Market for Neurostimulation Devices, by Region, Through 2026
Table 14: Global Market for Neurostimulation Devices, by Therapeutic Application, Through 2026
Table 15: Implantable Neurostimulation Devices Approved, January 2018-January 2021
Table 16: Currently Available Spinal Cord Stimulation Systems
Table 17: Currently Available Deep Brain Stimulation Systems
Table 18: Currently Available Sacral Nerve Stimulation Systems
Table 19: Currently Available Vagus Nerve Stimulation Systems
Table 20: U.S. FDA-Approved Transcutaneous Electrical Nerve Stimulation Systems for Pain Relief Treatment, January 2015-March 31, 2021
Table 21: U.S. FDA-Approved Transcutaneous Electrical Nerve Stimulation Systems for Treatment of Migraine Pain Relief, January 2015-March 31, 2021
Table 22: Currently Available Phrenic Nerve Stimulation Systems for Respiratory Insufficiency
Table 23: Currently Available Hypoglossal Nerve Stimulation Systems for Respiratory Insufficiency
Table 24: Currently Available Peripheral Nerve Stimulation Systems
Table 25: Currently Available Transcranial Magnetic Stimulating Systems
Table 26: Currently Available Gastric Electrical Stimulation System
Table 27: Neurostimulation Stimulation Product Pipeline Highlights
Table 28: Active Clinical Trials on Spinal Cord Stimulation Technology
Table 29: Active Clinical Trials on DBS Technology
Table 30: Active Clinical Trials on VNS Technology
Table 31: Active Clinical Trials on Sacral Nerve Stimulation Technology
Table 32: Active Clinical Trials on Peripheral Nerve Stimulation Technology
Table 33: Active Clinical Trials on Hypoglossal Nerve Stimulation Technology
Table 34: Global Market Shares of Leading Companies in Spinal Cord Stimulation Devices, 2020
Table 35: Global Market Shares of Leading Companies in Deep Brain Stimulation Devices, 2020
Table 36: Global Market Shares of Leading Companies in Sacral Nerve Stimulation Devices, 2020
Table 37: Global Market Shares of Leading Companies in Vagus Nerve Stimulation Devices, 2020
Table 38: Global Market Shares of Leading Companies in Hypoglossal Nerve Stimulation Devices, 2020
Table 39: Global Market Shares of Leading Companies in Transcranial Magnetic Stimulation Devices, 2020
Table 40: Acronyms Used in This Report

List of Figures
Summary Figure: Global Market for Neurostimulation Devices, by Type, 2020-2026
Figure 1: Global Market Shares of Neurostimulation Devices, by Type, 2020
Figure 2: Global Market Shares of Spinal Cord Stimulation Devices, by Region, 2020
Figure 3: Global Market Shares of Transcutaneous Electrical Nerve Stimulation Devices, by Region, 2020
Figure 4: Global Market Shares of Deep Brain Stimulation Devices, by Region, 2020
Figure 5: Global Market Shares of Sacral Nerve Stimulation Devices, by Region, 2020
Figure 6: Global Market Shares of Vagus Nerve Stimulation Devices, by Region, 2020
Figure 7: Global Market Shares of Hypoglossal Nerve Stimulation Devices, by Region, 2020
Figure 8: Global Market Shares of Transcranial Magnetic Stimulation Devices, by Region, 2020
Figure 9: Global Market Shares of Other Types of Neurostimulation Devices, by Region, 2020
Figure 10: Global Market Shares of Other Neurostimulation Devices, by Region, 2020
Figure 11: Global Market Shares of Neurostimulation Devices, by Therapeutic Application, 2020
Figure 12: Global Market Shares of Leading Companies in Spinal Cord Stimulation Devices, 2020
Figure 13: Global Market Shares of Leading Companies in Deep Brain Stimulation Devices, 2020
Figure 14: Global Market Shares of Leading Companies in Sacral Nerve Stimulation Devices, 2020
Figure 15: Global Market Shares of Leading Companies in Vagus Nerve Stimulation Devices, 2020
Figure 16: Global Market Shares of Leading Companies in Hypoglossal Nerve Stimulation Devices, 2020
Figure 17: Global Market Shares of Leading Companies in Transcranial Magnetic Stimulation Devices, 2020

Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Abbott Laboratories
  • Brainsway Ltd.
  • Laborie Inc.
  • Nalu Medical Inc.
  • Neurosigma Inc.
  • Respicardia Inc.

The human nervous system works as the head commander of the human body and medical science community have long believed that it has huge potential in treatment of human body disorders.

Neurostimulation technology involves alteration or modulation of nerves. Neurostimulation devices deliver electrical current or magnetic impulses directly to nerves to modify their activities.

In the last 25-30 years, neurostimulation has emerged as one of the most dynamic and exciting therapy field that has been actively investigated for treatment of a range of clinical conditions including chronic pain, movement disorders (Parkinson’s disease, tremor, dystonia and others), epilepsy, psychiatric disorders, functional restoration, cardiovascular disorders, gastrointestinal disorders and genitourinary disorders. It is also referred as “drug-free solutions.” Currently, the potential of neurostimulation technology is actively being explored in several other clinical conditions including obesity, tinnitus and central nerve system disorders.

Given the vast size of the potential treatment population and ongoing scientific discoveries and technological advances in neurostimulation technologies, the neurostimulation devices’ market is poised for significant growth. For example, according to the WHO, epilepsy is one of the most common neurological diseases globally, affecting around 50 million people around the world. According to the CDC, an estimated 50 million adults suffered from chronic pain in the U.S. in 2016, including 19.6 million adults who had high-impact chronic pain. Moreover, with growing geriatric populations and increasing trend toward the use of nondrug therapies, greater expectations for quality of life, and improved patient attitudes toward receiving medical attention, the neurostimulation technology market is expected to grow significantly in coming years.

This market is experiencing significant growth, largely driven by favorable demographic trends, focus on reducing opioid usage and product innovations.

Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Avery Biomedical Devices Inc.
  • Axonics Modulation Technologies Inc.
  • Bioinduction Ltd.
  • Bioness Inc.
  • Biowave Corp.
  • Boston Scientific Corp.
  • Brainsway Ltd.
  • Cochlear Americas
  • CVRX Inc.
  • Electrocore Inc.
  • Inspire Medical Systems Inc.
  • Integer Holdings Corp.
  • Laborie Inc.
  • LivaNova plc
  • Mag & More GmbH
  • Magstim Inc.
  • Medtronic plc
  • Nalu Medical Inc.
  • Neuromed Consulting Inc.
  • Neurometrix Inc.
  • Neuronetics Inc.
  • Neuropace Inc.
  • Neurosigma Inc.
  • Neurovalens Ltd.
  • Nevro Corp.
  • Nexstim plc
  • Nyxoah SA
  • Respicardia Inc.
  • Soterix Medical Inc.
  • Stimwave LLC
  • Synapse Biomedical Inc.
  • Tonica Elektronik A/S
  • Xavant Technology (Pty) Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll